AbbVie (ABBV) Tops Q4 EPS by 1c

AbbVie (NYSE: ABBV) reported Q4 EPS of $1.20, $0.01 better than the analyst estimate of $1.19. Revenue for the quarter came in at $6.78 billion versus the consensus estimate of $6.92 billion.

For earnings history and earnings-related data on AbbVie (ABBV) click here.

You May Also Be Interested In

• The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It
• Micron Technology (MU) Tops Q3 EPS by $4.62, Guidance Beats
• SanDisk stock target lifted by Citi on continued demand strength